It’s easy to think of cancer as a death sentence, something to be afraid of but that isn’t always so. .
Chronic myeloid leukemia (CML) is a case in point. Before the advent of Gleevec, patients could be reasonably expected to live for 3-4 years unless they were young enough for a transplant, assuming they met the eligibility criteria.
In a post-Gleevec world, patients are now surviving for at least 7 years and 10 years is probably not unrealistic. The first patient entered the late stage trials in Feb 1998. We are now 10 years on from that historic date.
I wonder how many of those patients are still alive now?